4D-150 Clinical Activity and Tolerability - 4D-150 demonstrates robust and durable clinical activity across all studied populations, including recently diagnosed patients with wet AMD[7] - 4D-150 exhibits a tolerability profile comparable to approved anti-VEGF agents[8] 4D-150 Injection-Free Rates in Wet AMD - In the severe wet AMD population, 44% of patients were injection-free through 52 weeks, with 48% requiring >1 injection and 8% requiring 1 injection, resulting in an 83% treatment burden reduction[13] - In the broad wet AMD population (including recently diagnosed), 70% of patients were injection-free through 52 weeks, with 20% requiring >1 injection and 10% requiring 1 injection, resulting in an 89% treatment burden reduction[16] - In the recently diagnosed wet AMD population, 87% of patients were injection-free through 52 weeks, with 13% requiring 1 injection, resulting in a 98% treatment burden reduction[19] 4D-150 Intraocular Inflammation (IOI) Profile - 4D-150 development is enabled by a favorable IOI profile, with IOI rates of 2-3%[22] 4FRONT Phase 3 Program Design - The 4FRONT Phase 3 program in treatment-naïve wet AMD is designed to maximize the probabilities of clinical, regulatory, and commercial success[10, 24, 35] - The 4FRONT-1 Phase 3 study's primary endpoint is BCVA noninferiority of 4D-150 3E10 vg/eye to Aflibercept 2mg Q8 weeks[33]

CORK, Ireland, July 8, 2025 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast: What: Johnson Controls Third Quarter Fiscal 2025 Earnings Conference CallWhen: Tuesday, July 29, 2025, at 8:30 a.m. ETHow: The conference call for investors can be accessed in the following ways: Live via webcast at http://investors.johnsoncontrols.com/news-and-events/events-and-presentations Note: A slide presentation wi ...

GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to beco ...

Custodied by Crypto.com, ETF to Launch Later This YearSARASOTA, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“Trump Media” or the “Company”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today the filing with the U.S. Securities and Exchange Commission of the initial registration statement on Form S-1 (the “Registration Statement”) for the Truth Social Crypto Blue Chip ...

Silver Spring, MD, July 08, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”) short for Blockchain Technology Consensus Solutions, a blockchain technology-focused company, today announced its strategic intent to raise $100 million in 2025 to acquire Ethereum. This initiative is part of the Company’s long-term vision to build the leading publicly traded company focused on Ethereum infrastructure while remaining one of the largest holders of ETH among public companies. “We believe th ...

--Nasdaq compliance follows reverse stock split previously announced on June 17, 2025LOS ALTOS, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced it has regained compliance with the Nasdaq Stock Market (“Nasdaq”) continued listing standard for minimum share price under Rule 5550(a)(2) of the Nasdaq Listing Qualifications. This updat ...

Net Asset Value Anticipated to be $9.00 to $9.50 Per Share Board of Directors Declares $0.25 Per Share Cash Dividend NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment portfolio for the second quarter ended June 30, 2025. “The second quarter was SuRo Capital’s best quarter since inception, as measured by the appreciation in NAV per share,” said Mark Klein, Chair ...

Yokneam Illit, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced a collaboration with Media Exceed Co., Ltd. (“Media Exceed”), a leading e-commerce company in Japan. Under this agreement, Media Exceed will serve as a non-exclusive reseller of Wearable Devices’ innovative Mudra Band and Mudra Link products in ...

Apple AI executive roaming Pang has reportedly left the company for a role at Meta. This is the latest move in the ongoing battle uh tech battle for top AI talent. Joining us now, Lauren Good, senior writer uh at Wired. These Lauren, it's good to see you. I mean, these guys, I look at it, they're so young, they must be like off the charts genius. If someone comes to me and says, "Mr. . Colonel, what what should I take in college. What are these people. What are they.Eee, what what computer uh program. Are t ...

Some large dividend stocks are still near the year's low and bring their dividend yield to an "astronomical" level in the face value, which may prevent the value investors from stepping in because they worry about aAdvanced education in economics, business management and engineering. Professional experience with product management and development in high tech industry, including advisory with multiple fintech startups. Have been investing in growth companies since 1998. Recent interest of investment also in ...